SACUVIB 100 SACUBITRIL 100mg. IP + VALSARTAN 51mg. IP

Sacuvib 100 tablets (Sacubitril 100 mg + Valsartan 51 mg) lower the risk of cardiovascular death and hospitalisation in chronic heart failure. Main uses: to reduce the risk of cardiovascular death and hospitalisation in adults with chronic heart failure; the benefit is clearly evident in patients with left ventricular ejection fraction below normal; for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in children aged one year and older; reduces NT-proBNP levels in heart failure; acts on the heart and blood vessels through two combined pathways (neprilysin inhibition and angiotensin II blockade).

Common side effects of Sacuvib 100 Tablet include low blood pressure (hypotension); high potassium levels (hyperkalemia); cough; dizziness; kidney problems or renal failure. Get medical help at once if you notice swelling of the face, lips, tongue or throat (angioedema) — the medicine must be stopped immediately and urgent medical help taken, as the airway needs to be monitored; harm to the developing baby if taken during pregnancy; marked rise in potassium levels.

Each Sacuvib 100 tablet contains Sacubitril 100 mg + Valsartan 51 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Sacuvib 100 Tablet only as your doctor advises.

The MRP of Sacuvib 100 Tablet is ₹229.69 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹175 and the PTS is ₹157.5.

Each Sacuvib 100 tablet contains Sacubitril 100 mg + Valsartan 51 mg. It comes in a pack of 10x10 (Alu Alu).

Sacubitril is changed in the body to LBQ657, which blocks neprilysin and raises natural peptides such as natriuretic peptides. Valsartan blocks the angiotensin II type-1 receptor, cutting the effects of angiotensin II and lowering aldosterone release. Together they act on the heart and blood vessels.

Must not be used by anyone allergic to sacubitril, valsartan or any other ingredient of the tablet. Must not be used by patients who have had swelling (angioedema) after earlier ACE inhibitor or ARB treatment. Must not be used together with ACE inhibitors. It must not be started within 36 hours of stopping an ACE inhibitor, and an ACE inhibitor must not be started within 36 hours of stopping this medicine. Must not be used with aliskiren in patients who have diabetes. If pregnancy is detected, the tablets must be stopped as soon as possible, as drugs acting on the renin-angiotensin system can harm the developing baby. Check with a doctor first if there is low blood pressure, kidney disease or high potassium, or if you are breastfeeding. Renal function and potassium should be monitored in susceptible patients.

Sacuvib 100 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.